Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease

Authors :: Charu Sabharwal
Vani Sundaraiyer
Yahong Peng
Lisa Moyer
Todd J. Belanger
Bradford D. Gessner
Luis Jodar
Kathrin U. Jansen
William C. Gruber
Daniel A. Scott
Wendy Watson
Source :: Human Vaccines & Immunotherapeutics. 18
Publication Year :: 2022
Publisher :: Informa UK Limited, 2022.
Abstract: NCT03760146, NCT03828617.

Subjects :: Adult
Pharmacology
Vaccines, Conjugate
Adolescent
Immunology
Middle Aged
Antibodies, Bacterial
Pneumococcal Infections
Pneumococcal Vaccines
Young Adult
Streptococcus pneumoniae
Immunogenicity, Vaccine
Humans
Immunology and Allergy

Tools